VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +10.0% ·
Aktienfluss -30.0% ·
neue Nettopositionen +9.1%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | — | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | — | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | — | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | — | — |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | — | 1.49M | $1.49M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 236.51K | +126.0% | $11.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 236.51K | +126.0% | $11.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passiv) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passiv) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passiv) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 27.39K | +25.8% | $1.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 27.39K | +25.8% | $1.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Millennium Management ✦ | 24.76K | Neu | $1.21M | 0.0% | New | 1 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 15.79K | — | $769,094 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 15.79K | — | $769,094 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 14.60K | -37.6% | $711,312 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (passiv) | 9.05K | +56.2% | $441,111 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 5.69K | Neu | $277,022 | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 5.69K | Neu | $277,022 | 0.0% | New | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 4.46K | — | $217,096 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 4.46K | — | $217,096 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Millennium Management | $1.21M | 0.0% |
| Citadel Advisors | $277,022 | 0.0% |
| Citadel Advisors | $277,022 | 0.0% |
Ausgestiegen
| Two Sigma Investments | $274,810 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 79 Inhaber, 40.44M Anteile, $716.36M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.